Michael Kasperkiewicz

4.0k total citations · 2 hit papers
80 papers, 2.5k citations indexed

About

Michael Kasperkiewicz is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Michael Kasperkiewicz has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pathology and Forensic Medicine, 49 papers in Rheumatology and 40 papers in Genetics. Recurrent topics in Michael Kasperkiewicz's work include Autoimmune Bullous Skin Diseases (66 papers), Urticaria and Related Conditions (48 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (40 papers). Michael Kasperkiewicz is often cited by papers focused on Autoimmune Bullous Skin Diseases (66 papers), Urticaria and Related Conditions (48 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (40 papers). Michael Kasperkiewicz collaborates with scholars based in Germany, United States and Poland. Michael Kasperkiewicz's co-authors include Detlef Zillikens, Enno Schmidt, Ralf J. Ludwig, P. Joly, Stefan Tukaj, Aimee Payne, Masayuki Amagai, Hayato Takahashi, Jun Yamagami and Christoph T. Ellebrecht and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Michael Kasperkiewicz

75 papers receiving 2.4k citations

Hit Papers

Pemphigus 2017 2026 2020 2023 2017 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pemphigus
    2017 327 citations Michael Kasperkiewicz, Detlef Zillikens et al. profile →
  2. Pemphigus
    2019 291 citations Enno Schmidt, Michael Kasperkiewicz et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kasperkiewicz Germany 27 1.8k 1.3k 1.2k 335 332 80 2.5k
Sabine Altrichter Germany 30 1.1k 0.6× 1.1k 0.9× 2.3k 1.8× 76 0.2× 850 2.6× 99 2.9k
Biagio Didona Italy 29 720 0.4× 328 0.3× 502 0.4× 144 0.4× 328 1.0× 88 2.1k
Toshihide Hara Japan 15 473 0.3× 114 0.1× 170 0.1× 54 0.2× 325 1.0× 37 995
Paola Cordiali‐Fei Italy 21 264 0.1× 136 0.1× 246 0.2× 56 0.2× 353 1.1× 39 1.0k
K Konrad Austria 18 408 0.2× 148 0.1× 193 0.2× 40 0.1× 175 0.5× 64 1.1k
James T. Rosenbaum United States 29 127 0.1× 119 0.1× 484 0.4× 151 0.5× 701 2.1× 63 2.2k
Emmanuel Karouzakis Switzerland 20 125 0.1× 109 0.1× 558 0.4× 223 0.7× 481 1.4× 30 1.9k
Hongjiang Qiao China 20 259 0.1× 153 0.1× 226 0.2× 20 0.1× 410 1.2× 46 1.1k
Patrick S. Asmawidjaja Netherlands 16 280 0.2× 58 0.0× 362 0.3× 174 0.5× 793 2.4× 36 1.3k
A M Irani United States 17 71 0.0× 274 0.2× 424 0.3× 105 0.3× 1.6k 4.8× 18 2.1k

Countries citing papers authored by Michael Kasperkiewicz

Since Specialization
Citations

This map shows the geographic impact of Michael Kasperkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kasperkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kasperkiewicz more than expected).

Fields of papers citing papers by Michael Kasperkiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kasperkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kasperkiewicz. The network helps show where Michael Kasperkiewicz may publish in the future.

Co-authorship network of co-authors of Michael Kasperkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kasperkiewicz. A scholar is included among the top collaborators of Michael Kasperkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kasperkiewicz. Michael Kasperkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasperkiewicz, Michael & David T. Woodley. (2023). COVID-19 and autoimmune bullous diseases: Lessons learned. Autoimmunity Reviews. 22(4). 103286–103286. 6 indexed citations
2.
Kasperkiewicz, Michael & Stefan Tukaj. (2022). Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19. Frontiers in Immunology. 13. 1080786–1080786. 4 indexed citations
3.
Tukaj, Stefan, Jagoda Mantej, Detlef Zillikens, et al.. (2022). Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita. Frontiers in Immunology. 13. 877958–877958. 7 indexed citations
4.
Tukaj, Stefan, Katja Bieber, Jasper N. Prüßmann, et al.. (2022). Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance. Archives of Dermatological Research. 315(10). 2921–2926. 3 indexed citations
5.
Zillikens, Detlef, et al.. (2019). Anti-Laminin-332-Schleimhautpemphigoid mit irreversiblem okulärem und tracheobronchialem Befall. Der Hautarzt. 70(5). 367–370. 3 indexed citations
6.
Schmidt, Enno, Michael Kasperkiewicz, & P. Joly. (2019). Pemphigus. The Lancet. 394(10201). 882–894. 291 indexed citations breakdown →
7.
Kasperkiewicz, Michael, Christian D. Sadik, Katja Bieber, et al.. (2016). Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options. Journal of Investigative Dermatology. 136(1). 24–33. 74 indexed citations
8.
Tukaj, Stefan, et al.. (2016). Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis. The Journal of Steroid Biochemistry and Molecular Biology. 173. 23–27. 18 indexed citations
9.
Hirose, Misa, Norito Ishii, Elena Pipi, et al.. (2014). Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 135(3). 768–775. 22 indexed citations
10.
Kasperkiewicz, Michael, et al.. (2014). Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis. Cell Stress and Chaperones. 19(6). 837–843. 32 indexed citations
11.
Schulze, Franziska, Michael Kasperkiewicz, Detlef Zillikens, & Enno Schmidt. (2013). Bullöses Pemphigoid. Der Hautarzt. 64(12). 931–945. 6 indexed citations
12.
Tukaj, Stefan, Konrad Kleszczyński, Stephanie Groth, et al.. (2013). Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid. PLoS ONE. 8(7). e70496–e70496. 34 indexed citations
13.
Beek, Nina van, Kristin Rentzsch, Christian Probst, et al.. (2012). Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet Journal of Rare Diseases. 7(1). 49–49. 83 indexed citations
14.
Kasperkiewicz, Michael, Falk Nimmerjahn, Misa Hirose, et al.. (2012). Genetic identification and functional validation of FcγRIV as key molecule in autoantibody‐induced tissue injury. The Journal of Pathology. 228(1). 8–19. 70 indexed citations
15.
Kasperkiewicz, Michael, Rüdiger Eming, Nicolas Hunzelmann, et al.. (2012). Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(10). 727–731. 35 indexed citations
16.
Kasperkiewicz, Michael, Iakov Shimanovich, Ralf J. Ludwig, et al.. (2011). Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients. Journal of the American Academy of Dermatology. 65(3). 552–558. 106 indexed citations
17.
Kasperkiewicz, Michael, Detlef Zillikens, & Enno Schmidt. (2011). Pemphigoid diseases: Pathogenesis, diagnosis, and treatment. Autoimmunity. 45(1). 55–70. 80 indexed citations
18.
Recke, Andreas, Elizabeth Schmidt, Juergen Westermann, et al.. (2010). Generation of blister-inducing autoantibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. Experimental Dermatology. 19(2). 182. 17 indexed citations
19.
Kasperkiewicz, Michael, Markus K Meier, Detlef Zillikens, & Enno Schmidt. (2010). Linear IgA Disease: Successful Application of Immunoadsorption and Review of the Literature. Dermatology. 220(3). 259–263. 17 indexed citations
20.
Kasperkiewicz, Michael, U. Hoppe, Detlef Zillikens, & Enno Schmidt. (2009). Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clinical and Experimental Dermatology. 35(6). 614–617. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Altrichter Breakdown of academic impact, for papers by Biagio Didona Breakdown of academic impact, for papers by Toshihide Hara Breakdown of academic impact, for papers by Paola Cordiali‐Fei Breakdown of academic impact, for papers by K Konrad Breakdown of academic impact, for papers by James T. Rosenbaum Breakdown of academic impact, for papers by Emmanuel Karouzakis Breakdown of academic impact, for papers by Hongjiang Qiao Breakdown of academic impact, for papers by Patrick S. Asmawidjaja Breakdown of academic impact, for papers by A M Irani
Rankless by CCL
2026